StonvexLoading…
StonvexStonvexStonvexCore line items from TRMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Annual 2026 2026-01-02 | Q4 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|
Revenue | $939.90M | $3.59B | $2.62B | $1.72B |
Operating Income | $144.00M | $592.00M | $375.80M | $225.30M |
Net Income | $98.90M | $424.00M | $267.40M | $155.90M |
EPS (Diluted) | $0.42 | $1.76 | $1.10 | $0.64 |
Total Assets | $8.99B | $9.31B | $9.02B | $9.10B |
Total Liabilities | $3.35B | $3.48B | $3.23B | $3.41B |
Cash & Equivalents | $234.10M | $253.40M | $232.70M | $265.90M |
Free Cash Flow OCF − CapEx | $268.60M | $360.90M | $206.20M | $89.60M |
Shares Outstanding | 231.70M | 236.00M | 237.90M | 238.00M |